PHASE-II TRIAL OF COMBINED 5-FLUOROURACIL PLUS DOXORUBICIN PLUS CISPLATIN (FAP REGIMEN) IN ADVANCED GASTRIC-CARCINOMA

被引：0
|
作者：
ROUGIER, P
DROZ, JP
THEODORE, C
PIOT, G
HERAIT, P
RUFFIE, P
CARDE, P
CVITKOVIC, E
机构：
来源：
CANCER TREATMENT REPORTS | 1987年 / 71卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1301 / 1302
页数：2
相关论文
共 50 条
  • [21] Randomized phase II trial of irinotecan, leucovorin and 5-fluorouracil (ILF) versus cisplatin plus ILF (PILF) for advanced gastric cancer
    Shin, D.
    Lee, S.
    Park, S.
    Park, J.
    Cho, E.
    Lee, J.
    Lee, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] A PHASE-II TRIAL OF 5-FLUOROURACIL AND RECOMBINANT INTERFERON-ALPHA-2A IN PREVIOUSLY UNTREATED METASTATIC GASTRIC-CARCINOMA
    PAZDUR, R
    AJANI, JA
    WINN, R
    BEARDEN, J
    BELT, RJ
    PILAT, S
    HALLINAN, R
    LEVIN, B
    CANCER, 1992, 69 (04) : 878 - 882
  • [23] PHASE-II TRIAL OF ETOPOSIDE, DOXORUBICIN (ADRIAMYCIN), AND CISPLATIN (EAP REGIMEN) IN ADVANCED GASTRIC-CANCER
    SPARANO, JA
    SCHWARTZ, EL
    SALVA, KM
    PIZZILLO, MF
    WADLER, S
    WIERNIK, PH
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (05): : 374 - 378
  • [24] DOXORUBICIN AND 5-FLUOROURACIL VERSUS DOXORUBICIN AND ORAL FTORAFUR IN THE TREATMENT OF ADVANCED GASTRIC-CANCER - A PHASE-II AND PHASE-III TRIAL
    VESTLEV, PM
    PEDERSEN, H
    ACTA ONCOLOGICA, 1990, 29 (07) : 945 - 946
  • [25] Paclitaxel (T) plus 5-fluorouraciL (5-FU): A novel and very active regimen for advanced gastric cancer (AGC). A phase II trial
    Murad, AM
    Guimaraes, RC
    Aragao, BC
    Ferreira, AF
    Schwartsmann, G
    Brundani, A
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1255 - 1255
  • [26] PHASE II TRIAL OF ENDOSTAR COMBINED WITH EPIRUBICIN, CISPLATIN AND 5-FLUOROURACIL IN PATIENTS WITH ADVANCED AND METASTATIC GASTRIC CANCER
    Zhu, X.
    ANNALS OF ONCOLOGY, 2012, 23 : 19 - 19
  • [27] EPIDOXORUBICIN AND HIGH-DOSE LEUCOVORIN PLUS 5-FLUOROURACIL IN ADVANCED GASTRIC-CANCER - A PHASE-II STUDY
    NERI, B
    GEMELLI, MT
    PANTALONE, D
    ANDREOLI, F
    BRUNO, S
    FABBRONI, S
    LEONE, V
    VALERI, A
    BORRELLI, D
    ANTI-CANCER DRUGS, 1993, 4 (03) : 323 - 326
  • [28] CONTINUOUS 5-FLUOROURACIL INFUSION IN ADVANCED GASTRIC-CARCINOMA
    MOYNIHAN, T
    HANSEN, R
    ANDERSON, T
    QUEBBEMAN, E
    BEATTY, P
    AUSMAN, R
    CLINICAL RESEARCH, 1987, 35 (06): : A864 - A864
  • [29] Final Results of a Phase 3 Study of Comparing Paclitaxel Plus 5-Fluorouracil versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma
    Chen, Y.
    Ye, J.
    Zhu, Z.
    Zhao, W.
    Li, L.
    Fan, M.
    Wu, C.
    Tang, H.
    Xu, G.
    Lin, Q.
    Li, J.
    Xia, Y.
    Yunhai, L.
    Zhou, J.
    Zhao, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S28 - S28
  • [30] A randomized phase 3 trial comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in Chemoradiotherapy for locally advanced esophageal carcinoma—the ESO-shanghai 1 trial protocol
    Yun Chen
    Zhengfei Zhu
    Weixin Zhao
    Ling Li
    Jinjun Ye
    Chaoyang Wu
    Huarong Tang
    Qin Lin
    Jiancheng Li
    Yi Xia
    Yunhai Li
    Jialiang Zhou
    Kuaile Zhao
    Radiation Oncology, 13
12345